SCHEMBL8409264

SCHEMBL8409264

CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(Cl)c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
LMNA P02545 3/20 0.47
AR P10275 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CES2 O00748 1/20 0.47
ABCB11 O95342 1/20 0.47
CYP1A2 P05177 1/20 0.47
GLA P06280 1/20 0.47
CYP3A4 P08684 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
CHRM1 P11229 1/20 0.47
CYP2C9 P11712 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
TBXA2R P21731 1/20 0.47
AADAC P22760 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP2C19 P33261 1/20 0.47
ADRA1A P35348 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8407132 0.88 ALDH1A1 (0.49) ALDH1A1LMNAARSMN1; SMN2CES2
SCHEMBL8407247 0.83 LMNA (0.47) ALDH1A1LMNAARSMN1; SMN2CES2
SCHEMBL8407371 0.83 ALDH1A1 (0.50) ALDH1A1LMNAARSMN1; SMN2CES2
SCHEMBL8407120 0.82 ALDH1A1 (0.47) ALDH1A1LMNAARSMN1; SMN2CES2
SCHEMBL8410361 0.81 LMNA (0.49) ALDH1A1LMNAARSMN1; SMN2CES2
SCHEMBL8409158 0.80 AR (0.69) ALDH1A1LMNAARSMN1; SMN2CES2
SCHEMBL8407214 0.79 ALDH1A1 (0.55) ALDH1A1LMNAARSMN1; SMN2CES2
SCHEMBL8410380 0.79 CXCR2 (0.55) ALDH1A1LMNAHTTGAACXCR1
SCHEMBL21461509 0.76 ALDH1A1 (0.49) ALDH1A1LMNAARSMN1; SMN2CES2
SCHEMBL31339760 0.76 ALDH1A1 (0.49) ALDH1A1LMNAARSMN1; SMN2CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5994362-A ADMINISTERING FINASTERIDE AND CASODEX MERCK & CO., INC. (US) 1999-11-30 US disclosed
EP-0514056-A2 Use of estrogens or antiandrogens for reversal of male sexual phenotype in poultry MERCK & CO. INC. (US) 1992-11-19 EP disclosed
WO-1992016233-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC CANCER CONTAINING A 5 ALPHA REDUCTASE INHIBITOR AND AN ANTIANDROGEN MERCK & CO., INC. (US) 1992-10-01 WO disclosed